Helicobacter Pylori Infections – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032
Helicobacter pylori (H. pylori) is a Gram-negative, helix-shaped, microaerophilic, flagellated bacterium capable of converting its shape from spiral to coccoid believed to be involved in the enhancement of bacterial survival in the host gastric microenvironment. H pylori cause acute gastritis characterized by neutrophil infiltration into the foveolar and surface epithelium and epithelial degenerative changes. H pylori cause a persistent infection in the majority of infected individuals. Long-term infection by H pylori results in chronic gastritis, a condition manifest as multiple pathologic entities. Chronic gastritis due to H pylori infection may be separated into distinct, clinically relevant phenotypes.
·
Nonatrophic pangastritis occurs in most H
pylori-infected individuals with no predisposition to peptic ulcer disease or
gastric atrophy.
·
Bacterial and host factors seem to influence
the type of gastroduodenal disease that is generated. As many as 16% of H
pylori-infected individuals in the United States develop duodenal ulcers in
addition to chronic active gastritis. An inverse relationship or paradox exists
between the incidence of duodenal ulcer disease and gastric adenocarcinoma.
Thelansis’s “Helicobacter Pylori
Infections Market Outlook, Epidemiology, Competitive
Landscape, and Market Forecast Report – 2021 To 2032" covers disease
overview, epidemiology, drug utilization, prescription share analysis,
competitive landscape, clinical practice, regulatory landscape, patient share,
market uptake, market forecast, and key market insights under the potential Helicobacter
Pylori Infections treatment modalities options for eight major markets (USA,
Germany, France, Italy, Spain, UK, Japan, and China).
KOLs insights
of Helicobacter Pylori Infections across 8 MM market from the centre of
Excellence/ Public/ Private hospitals participated in the study. Insights
around current treatment landscape, epidemiology, clinical characteristics,
future treatment paradigm, and Unmet needs.
Helicobacter Pylori Infections Market Forecast Patient
Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs
with sourcing, Market Event, and Product Event, Country specific Forecast
Model, Market uptake and patient share uptake, Attribute Analysis, Analog
Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment